Cardiogenic shock in Non-ST elevated AMI patients in a rural tertiary care hospital in Eastern India
Abstract
Introduction: Acute Myocardial infarction is one of the leading causes of morbidity and mortality worldwide. Cardiogenic Shock is the leading cause of death in patients hospitalised for acute MI. Although there is substantial evidence for a benefit of reperfusion therapy for ST elevation MI, the best treatment strategy for patients with non-ST segment elevated MI is less well defined. Outcome and prognosis differs with the presence or absence of ST segment elevation. Most of the studies have been done on urban population.
Objective: To determine the frequency and profile of Non-ST elevated MI. Any differences in profile in a Rural population with different social and economic structure will also be documented.
Methods: In this descriptive cross-sectional study conducted in Medicine department, Malda Medical College & Hospital, WestBengal, India 100 patients of non STEMI are selected by using consecutive non probability sampling technique. After taking ethical clearance from Institution and consent from patients and their relatives, 100 patients of non STEMI are enrolled as per inclusion and exclusion criteria. They are evaluated for cardiogenic shock on the basis standard clinical examination and are managed as per protocol. All relevant data are recorded in predesigned proforma.
Results: Out of 100 patients, 68 are male and 32 are female. Mean age of the patients is 60 + 1.26 years and majority of them are in the age group of 61-70 years(41%). 5% patients of non STEMI developed cardiogenic shock and majorities are male and more than 50% of patients with cardiogenic shock with non STEMI are above 70 years old.
Conclusion: Frequency and Profile is comparable to other studies. This rising trendin a rural population of a developing country is due to probably more urbanisationrelated to change in food habits and life style changes.
Downloads
References
Teoh M, Lalondrelle S, Roughton M, Gro-cott-Mason R, Dubrey SW. ACS and its presentation in Asian Caucasian patients in Britain. Heart 2007; 93: 183-8.
Rosamond W, Flegal K, Friday G,FurieK , Go A,GreenlundK,et al. Heart disease and stroke statistics-2007 update: A report from the American heart association statisticcommittee and stroke statistics subcommittee. Circulation 2007: 115.115(5):e69-171.
Jafary MH, Samad A ,IshaqM,Vohra EA. Profile of acute myocardial infarction(AMI) in Pakistan. Pak J Med Sci 2007; 23(4): 485-9.
Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes.Circulation.2008 Feb 5;117(5):686-97. doi: https://doi.org/10.1161/CIRCULATIONAHA.106.613596.
Boden WE, O'rourke RA, Teo KK, hartigan PM, Maron DJ, Kostuk W, et al. The evolving pattern of symptomatic coronary artery disease in the United States and Canada: Baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Am J Cardiol 2007; 99(2): 208-12.
Saleheen D, Zaidi M, Rasheed A, Ahmad U, Hakeem A, Murtaza M, et al. The Pakistan risk of myocardial infraction study: A resource for the study of genetic, lifestyle and other determinants of myocardial infraction in south Asia ,Eur J Epedemiol 2009; 24(6): 329-38.doi: https://doi.org/10.1007/s10654-009-9334-y. Epub 2009 Apr 30.
Rosamond W Flegal K, Furie K, Go A, Greenlund K, Hassan N et al. Heart disease and stroke statistics- 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117(4): e25-146.
Holmes DR Jr, Berger PB, Hochman JS, Granger CB, Thompson TD, Califfic RM, et al. Cardiogenic shock in patient with acute ischemic syndromes with and without ST-segment elevation. Circulation. 1999 Nov 16; 100(20): 2067-73.
Jacobs AK, French JK, Col J, Sleeper LA, Slater JN, Carnendran L, et al. Cardiogenic shockwith non-ST-segment elevation myocardial infraction: a report from theSHOCKtrial registry. J Am Coll Cardiol. 2000; 36: 1901-96.
Goldberg RJ, Gore JM, Alpert JS,Osganian V, de Groot J, Bade J,et al. Cardiogenic shock after acute myocardial infraction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med. 1991 Oct 17; 325 (16): 1117-22.
H olmes DR Jr,Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, Califf RM, Berger PB, Topol EJ. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I Investigators. Global Utilization of Streptokinase and TissuePlasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995; 26(3):668-74.
Polonsk L, Gasior M, Gierlotka M, Kalarus Z, Cielinski A, DubialSJet al. Polish registry of acute coronary syndromes (PL-ACS) characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol Pol 2007; 65: 861-72.
Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction: etiologies, management and outcome: a report from the SHOCK trial registry. J Am Coll Cardiol. 2000;36:1063–70.
Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularisation on mortality. Results of an international registry. SHOCK registry investigators. Circulation. 1995;91:873–81.
Bhardwaj R, Kandoria A, Sharma R Myocardial infarction in young adults-risk factors and pattern of coronary artery involvement.Niger Med J. 2014 Jan;55(1):44-7. doi: https://dx.doi.org/10.4103%2F0300-1652.128161.
OAI - Open Archives Initiative
